Medicover AB (publ) (MCOV_B) Q2 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Welcome to the MediCover Q22026 report presentation. For the first part of the conference call, the participants will be in listen-only mode. During the questions and answers session, participants are able to ask questions by dialing pound key 5 on their telephone keypad. Now I will hand the conference over to the speakers, CEO John Stubbington and CFO Anand Patel. Please go ahead. Good morning, everybody. It's John here. Welcome to our Q2 2026 report. I think we've got a quarter of positive progression, which we're very pleased with. You can see it's another quarter of double-digit organic revenue growth and margin expansion, which is really what we're aiming for. Strong organic growth of 11.8%. And this is our sixth quarter of improved margins. So we're very pleased with that. It's a record that we're proud of and hope to continue as we go forward. Just a reminder for everybody, this particular quarter has a very strong comparable base. Last year, we made significant movements upwards, so it's even more pleasing to see the progress that we've actually made. And a year or so ago, probably just a year and a quarter, there was a lot of talk about India and what we're going to do in terms of the growth for India. But you can see that over Q1 and Q2, we've had Thank you very much. and leverage was at 2.9. So revenue 640.4, very respectable in terms of the growth rate. You can see that from an organic perspective, it's 11.8, which is very credible indeed. Adjusted EBITDA 109.2, very pleasing to see that and to see our progress. And you can see also with the adjusted EBITDA margin at 17.1, the increase there is not as big, but as I said, there's a very high comparable. So just to see that move in the right direction is very positive for us. Operating cash flow is 73.6%. T...